Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma.

Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U.

Leuk Lymphoma. 2019 Jun 6:1-5. doi: 10.1080/10428194.2019.1620946. [Epub ahead of print]

PMID:
31167584
2.

Facing erythrocytosis: Results of an international physician survey.

Rumi E, McMullin MF, Harrison C, Ellis MH, Barzilai M, Sarid N, Mesa R, Paoli C, Angona A, Sant'Antonio E, Ferretti VV, Cavalloni C, Casetti IC, Trotti C, Barbui T.

Am J Hematol. 2019 May 31. doi: 10.1002/ajh.25545. [Epub ahead of print] No abstract available.

PMID:
31148218
3.

Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.

Arbel R, Sergienko R, Hammerman A, Dotan-Greenberg S, Batat E, Avnery O, Greenberg D, Ellis MH.

Heart. 2019 Apr 10. pii: heartjnl-2018-314476. doi: 10.1136/heartjnl-2018-314476. [Epub ahead of print]

PMID:
30971403
4.

[PRACTICAL ADVICE FOR THE APPROPRIATE USE OF DIRECT ORAL ANTICOAGULANTS].

Ellis MH, Shapira S, Avnery O.

Harefuah. 2019 Mar;158(3):200-204. Review. Hebrew.

PMID:
30916511
5.

Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation.

Arbel R, Sergienko R, Hammerman A, Greenberg-Dotan S, Batat E, Avnery O, Ellis MH.

Am J Med. 2019 Feb 15. pii: S0002-9343(19)30134-2. doi: 10.1016/j.amjmed.2019.01.025. [Epub ahead of print]

PMID:
30776320
6.

A Genetic Origin? Purpura Fulminans.

Avnery O, Kenet G, Ellis MH.

Am J Med. 2019 Mar;132(3):327-328. doi: 10.1016/j.amjmed.2018.10.003. Epub 2018 Oct 24. No abstract available.

PMID:
30367859
7.

Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study.

Ellis MH, Dotan SG, Hammerman A, Battat E, Derazne E, Avnery O.

Thromb Res. 2018 Sep;169:140-142. doi: 10.1016/j.thromres.2018.07.024. Epub 2018 Jul 25. No abstract available.

PMID:
30056294
8.

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms.

De Stefano V, Carobbio A, Di Lazzaro V, Guglielmelli P, Iurlo A, Finazzi MC, Rumi E, Cervantes F, Elli EM, Randi ML, Griesshammer M, Palandri F, Bonifacio M, Hernandez-Boluda JC, Cacciola R, Miroslava P, Carli G, Beggiato E, Ellis MH, Musolino C, Gaidano G, Rapezzi D, Tieghi A, Lunghi F, Loscocco GG, Cattaneo D, Cortelezzi A, Betti S, Rossi E, Finazzi G, Censori B, Cazzola M, Bellini M, Arellano-Rodrigo E, Bertozzi I, Sadjadian P, Vianelli N, Scaffidi L, Gomez M, Cacciola E, Vannucchi AM, Barbui T.

Blood Cancer J. 2018 Feb 28;8(3):25. doi: 10.1038/s41408-018-0048-9.

9.

Ruxolitinib for the management of myelofibrosis: Results of an international physician survey.

Ellis MH, Koren-Michowitz M, Lavi N, Vannucchi AM, Mesa R, Harrison CN.

Leuk Res. 2017 Oct;61:6-9. doi: 10.1016/j.leukres.2017.08.002. Epub 2017 Aug 10.

PMID:
28843161
10.

Ambulatory Versus In-Hospital Treatment of Proximal Lower-Limb Deep Vein Thrombosis in Adults: A Retrospective Cohort Study.

Mausbach LS, Avnery O, Ellis MH.

Clin Appl Thromb Hemost. 2017 Oct;23(7):859-864. doi: 10.1177/1076029616677801. Epub 2016 Nov 10.

PMID:
27831528
11.

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

De Stefano V, Vannucchi AM, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Pieri L, Rossi E, Guglielmelli P, Betti S, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola E, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Barbui T.

Blood Cancer J. 2016 Nov 4;6(11):e493. doi: 10.1038/bcj.2016.103.

12.

Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey.

Koren-Michowitz M, Lavi N, Ellis MH, Vannucchi AM, Mesa R, Harrison CN.

Ann Hematol. 2017 Jan;96(1):87-92. doi: 10.1007/s00277-016-2826-4. Epub 2016 Oct 13.

PMID:
27734130
13.

Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study.

Ellis MH, Neuman T, Bitterman H, Dotan SG, Hammerman A, Battat E, Eikelboom JW, Ginsberg JS, Hirsh J.

Eur J Intern Med. 2016 Sep;33:55-9. doi: 10.1016/j.ejim.2016.05.023. Epub 2016 Jun 11.

PMID:
27296588
14.

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

De Stefano V, Ruggeri M, Cervantes F, Alvarez-Larrán A, Iurlo A, Randi ML, Elli E, Finazzi MC, Finazzi G, Zetterberg E, Vianelli N, Gaidano G, Rossi E, Betti S, Nichele I, Cattaneo D, Palova M, Ellis MH, Cacciola R, Tieghi A, Hernandez-Boluda JC, Pungolino E, Specchia G, Rapezzi D, Forcina A, Musolino C, Carobbio A, Griesshammer M, Sant'Antonio E, Vannucchi AM, Barbui T.

Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

PMID:
27113812
15.
16.

Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice.

Ellis MH, Lavi N, Mishchenko E, Dally N, Lavie D, Courevitch A, Gutwein O, Bulvik S, Braester A, Chubar E, Tavor S, Duek A, Kirgner I, Koren-Michowitz M.

Leuk Res. 2015 Aug 12. pii: S0145-2126(15)30356-8. doi: 10.1016/j.leukres.2015.08.003. [Epub ahead of print]

PMID:
26364797
17.

No(AC) free lunches: promises and pitfalls of novel oral anticoagulants.

Ellis MH.

Isr Med Assoc J. 2014 Jun;16(6):377-8. No abstract available.

18.

Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: a physician survey.

Ellis MH, Lavi N, Vannucchi A, Harrison C.

Thromb Res. 2014 Aug;134(2):251-4. doi: 10.1016/j.thromres.2014.04.032. Epub 2014 May 9.

PMID:
24842684
19.

Immune thrombocytopenia: recent progress in pathophysiology and treatment.

Abadi U, Yarchovsky-Dolberg O, Ellis MH.

Clin Appl Thromb Hemost. 2015 Jul;21(5):397-404. doi: 10.1177/1076029614526639. Epub 2014 Mar 12. Review.

PMID:
24623064
20.

A current approach to superficial vein thrombosis.

Ellis MH, Fajer S.

Eur J Haematol. 2013 Feb;90(2):85-8. doi: 10.1111/ejh.12044. Epub 2013 Jan 7. Review.

PMID:
23181477
21.

Alteration of lipids and the transcription of lipid-related genes in myelodysplastic syndromes via a TP53-related pathway.

Ellis MH, Baraf L, Shaish A, Har-Zahav A, Harats D, Ashur-Fabian O.

Exp Hematol. 2012 Jul;40(7):540-547.e1. doi: 10.1016/j.exphem.2012.02.003. Epub 2012 Feb 27.

PMID:
22381680
22.

Removal of retrievable vena cava filters in routine practice: a multicenter study.

Michaelov T, Blickstein D, Levy D, Berliner S, Ellis MH.

Eur J Intern Med. 2011 Dec;22(6):e87-9. doi: 10.1016/j.ejim.2011.08.023. Epub 2011 Sep 16.

PMID:
22075319
23.

Prolonged Blood Storage Does Not Effect Survival in an Animal Model of Hemorrhagic Shock.

Abadi U, Butenero G, Kogan T, Ziv O, Paran H, Ellis MH.

Transfus Med Hemother. 2011;38(4):272-276. Epub 2011 Jul 15.

24.

Blood sampling through peripheral venous catheters is reliable for selected basic analytes in children.

Berger-Achituv S, Budde-Schwartzman B, Ellis MH, Shenkman Z, Erez I.

Pediatrics. 2010 Jul;126(1):e179-86. doi: 10.1542/peds.2009-2920. Epub 2010 Jun 21.

PMID:
20566616
25.

Prevention of venous thromboembolism in medical patients: recent advances and future directions.

Hellmann I, Ellis MH.

Isr Med Assoc J. 2009 Dec;11(12):753-7. Review. No abstract available.

26.

Late relapse of Hodgkin's lymphoma presenting as fatal hematemesis caused by an esophago-tracheo-arterial fistula.

Kutchuk M, Edelstein Y, Ellis MH.

Isr Med Assoc J. 2009 Oct;11(10):637-8. No abstract available.

27.

Prevalence of anemia among unselected adults with diabetes mellitus and normal serum creatinine levels.

Goldhaber A, Ness-Abramof R, Ellis MH.

Endocr Pract. 2009 Nov-Dec;15(7):714-9. doi: 10.4158/EP09119.ORR.

PMID:
19625242
28.

Transfusion-related acute lung injury following intravenous anti-D administration in an adolescent.

Berger-Achituv S, Ellis MH, Curtis BR, Wolach B.

Am J Hematol. 2008 Aug;83(8):676-8. doi: 10.1002/ajh.21185.

29.

Management of immune thrombocytopenic purpura in pregnancy.

Sukenik-Halevy R, Ellis MH, Fejgin MD.

Obstet Gynecol Surv. 2008 Mar;63(3):182-8. doi: 10.1097/OGX.0b013e318164013c. Review.

PMID:
18279544
30.

Molecular mapping of genes for Coleoptile growth in bread wheat (Triticum aestivum L.).

Rebetzke GJ, Ellis MH, Bonnett DG, Richards RA.

Theor Appl Genet. 2007 May;114(7):1173-83. Epub 2007 Feb 9.

PMID:
17294164
31.

A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two cases.

Ellis MH, Ashur-Fabian O, Trakhtenbrot L, Amariglio N.

Isr Med Assoc J. 2006 Dec;8(12):836-7. No abstract available.

32.

Hemorrhagic complications in patients treated with anticoagulant doses of a low molecular weight heparin (enoxaparin) in routine hospital practice.

Ellis MH, Hadari R, Tchuvrero N, Shapira S, Kovlenko I, Kozmiakova M, Zissin R, Elis A.

Clin Appl Thromb Hemost. 2006 Apr;12(2):199-204.

PMID:
16708122
33.

Retrospective analysis of the use of inferior vena cava filters in routine hospital practice.

Dovrish Z, Hadary R, Blickstein D, Shilo L, Ellis MH.

Postgrad Med J. 2006 Feb;82(964):150-3.

34.

C-reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity.

Twito O, Reshef T, Ellis MH.

Eur J Haematol. 2006 Mar;76(3):206-9.

PMID:
16451395
35.

Hemorrhagic complications of low molecular weight heparins (LMWHs).

Ellis MH.

Isr Med Assoc J. 2005 Dec;7(12):822-3. No abstract available.

36.

Molecular mapping of gibberellin-responsive dwarfing genes in bread wheat.

Ellis MH, Rebetzke GJ, Azanza F, Richards RA, Spielmeyer W.

Theor Appl Genet. 2005 Aug;111(3):423-30. Epub 2005 Jun 21.

PMID:
15968526
37.

High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors.

Segev A, Ellis MH, Segev F, Friedman Z, Reshef T, Sparkes JD, Tetro J, Pauzner H, David D.

Int J Cardiol. 2005 Feb 28;98(3):421-4.

PMID:
15708174
38.

Artificial neural networks for anticoagulant management--think again!

Ellis MH.

Isr Med Assoc J. 2004 Dec;6(12):770-1. No abstract available.

39.

Preventing venous thromboembolism in acute medical patients.

Elis A, Ellis MH.

QJM. 2004 Dec;97(12):797-801.

PMID:
15569811
40.
41.
42.

MADS box genes control vernalization-induced flowering in cereals.

Trevaskis B, Bagnall DJ, Ellis MH, Peacock WJ, Dennis ES.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13099-104. Epub 2003 Oct 13.

43.

The effect of plasma depletion of platelet concentrates on platelet aggregation and phosphatidylserine expression.

Zilber M, Friedman Z, Shapiro H, Shapira S, Radnay J, Ellis MH.

Clin Appl Thromb Hemost. 2003 Jan;9(1):39-44.

PMID:
12643322
44.

Hemorrhage caused by invasive procedures and trauma in patients treated with low molecular weight heparin.

Ellis MH, Zissin R.

Isr Med Assoc J. 2002 Nov;4(11):1087-8. No abstract available.

45.

Increased level of hemoglobin 1 enhances survival of hypoxic stress and promotes early growth in Arabidopsis thaliana.

Hunt PW, Klok EJ, Trevaskis B, Watts RA, Ellis MH, Peacock WJ, Dennis ES.

Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17197-202. Epub 2002 Dec 16.

46.

Semidwarf (sd-1), "green revolution" rice, contains a defective gibberellin 20-oxidase gene.

Spielmeyer W, Ellis MH, Chandler PM.

Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):9043-8. Epub 2002 Jun 19.

47.

Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.

Presseizen K, Friedman Z, Shapiro H, Radnay J, Ellis MH.

Clin Appl Thromb Hemost. 2002 Jan;8(1):33-9.

PMID:
11991237
48.

The rare Lu:-6 phenotype in Israel and the clinical significance of anti-Lu6.

Yahalom V, Ellis MH, Poole J, Rahimi-Levene N, Shinar E, DaCosta Y, Manny N, Levene C.

Transfusion. 2002 Feb;42(2):247-50.

PMID:
11896342
49.

Overexpression of alcohol dehydrogenase or pyruvate decarboxylase improves growth of hairy roots at reduced oxygen concentrations.

Shiao TL, Ellis MH, Dolferus R, Dennis ES, Doran PM.

Biotechnol Bioeng. 2002 Feb 15;77(4):455-61.

PMID:
11787018
50.

Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.

Scott MB, Ellis MH, Cruz-Rivera M, Fitzpatrick S, Smith JA.

Ann Allergy Asthma Immunol. 2001 Dec;87(6):488-95.

PMID:
11770696

Supplemental Content

Loading ...
Support Center